Conference - Cambridge, MA, United States
The kinase inhibitor field is maturing. This conference is designed to examine the question of what lays ahead, what is in store for the pharmaceutical industry and what new avenues are opening up be in regards to technologies and methods used or in regards to novel targets and therapeutic approaches explored. What novel kinase indications are “out there”, in addition to cancer as a target, what other therapeutic areas are blossoming?
Key issues such as addressing resistance, selectivity versus safety, developing lead compounds, integrating chemistry and biology, using promising techniques such as fragment – and structure based design as well as optimizing PK and PD and how to analyze the flood of data available will be addressed in this conference.
(Photo courtesy of http://www.healthtech.com/kin)
Royal Sonesta Hotel Boston, Cambridge, MA
Monday, June 4, 2012 to Wednesday, June 6, 2012 (8:00 AM - 6:00 PM)
Contact: Nilufer Donmez (ndonmez@healthtech.com)
Phone: 781-247-6257
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
